HNRNPA2B1 regulates tamoxifen- and fulvestrant-sensitivity and hallmarks of endocrine resistance in breast cancer cells

This publication has 134 references indexed in Scilit:

• CXCR4 activation maintains a stem cell population in tamoxifen-resistant breast cancer cells through AhR signalling
  British Journal of Cancer, 2012
• The turnover of estrogen receptor α by the selective estrogen receptor degrader (SERD) fulvestrant is a saturable process that is not required for antagonist efficacy
  Biochemical Pharmacology, 2011
• Role of calcineurin, hnRNPA2 and Akt in mitochondrial respiratory stress-mediated transcription activation of nuclear gene targets
  Biochimica et Biophysica Acta (BBA) - Bioenergetics, 2010
• Reversible Ponceau staining as a loading control alternative to actin in Western blots
  Analytical Biochemistry, 2010
• Differential Subcellular Distributions and Trafficking Functions of hnRNP A2/B1 Spliceoforms
  Traffic, 2010
• MicroRNA-221/222 Negatively Regulates Estrogen Receptorα and Is Associated with Tamoxifen Resistance in Breast Cancer
  Journal of Biological Chemistry, 2008
• Analyzing real-time PCR data by the comparative CT method
  Nature Protocols, 2008
• Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling
  Oncogene, 2003
• Gene expression profiling predicts clinical outcome of breast cancer
  Nature, 2002
• Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
  Proceedings of the National Academy of Sciences, 2001